EP Patent

EP1652926B1 — Crystalline epothilone d

Assigned to Kosan Biosciences Inc · Expires 2009-09-30 · 17y expired

What this patent protects

Recombinant Myxococcus host cells can be used to produce polyketides, including epothilone and epothilone analogs that can be purified from the fermentation broth and crystallized.

USPTO Abstract

Recombinant Myxococcus host cells can be used to produce polyketides, including epothilone and epothilone analogs that can be purified from the fermentation broth and crystallized.

Drugs covered by this patent

Patent Metadata

Patent number
EP1652926B1
Jurisdiction
EP
Classification
—
Expires
2009-09-30
Drug substance claim
No
Drug product claim
No
Assignee
Kosan Biosciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.